SCHEMBL2668083

SCHEMBL2668083

CCOC(C)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11370127 0.78
SCHEMBL31490933 0.77
SCHEMBL8272284 0.73
SCHEMBL8991462 0.73 LMNA (0.53)
SCHEMBL157863 0.73
SCHEMBL6375588 0.73
SCHEMBL8642009 0.73
Methylene Chloride SCHEMBL7997683 0.71 LMNA (0.80)
SCHEMBL3799671 0.71
Monochloroacetal SCHEMBL483679 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823439-A Method for efficiently recycling waste plastics 东莞市众一新材料科技有限公司 2025-04-15 CN disclosed
EP-2668182-B1 IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION 4SC DISCOVERY GMBH (DE) 2017-11-01 EP disclosed
WO-2007075847-A2 GLUCOKINASE ACTIVATORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-07-05 WO disclosed
EP-0499327-B1 Steroid compounds active on the cardiovascular system ZAMBON SPA (IT) 1996-11-13 EP disclosed
US-5426179-A Substituted androstanes ZAMBON GROUP S.P.A. (IT) 1995-06-20 US disclosed
EP-0499327-A1 Steroid compounds active on the cardiovascular system ZAMBON GROUP S.p.A. (IT) 1992-08-19 EP disclosed